| Literature DB >> 28867638 |
Ye Li1, Tongkai Chen1, Xiaoqing Miao1, Xiang Yi2, Xueqing Wang3, Haitao Zhao4, Simon Ming-Yuen Lee1, Ying Zheng5.
Abstract
The blood brain barrier (BBB) is the network of capillaries that controls the passage of substances from the blood into the brain and other parts of the central nervous system (CNS). As this barrier is the major obstacle for drug delivery into CNS, a credible BBB model is very necessary to assess the BBB permeability of novel neuroactive compounds including thousands of bioactive compounds which have been extracted from medicinal plants and have the potential for the treatment of CNS diseases. Increasing reports indicated that zebrafish has emerged as a timely, reproducible model for BBB permeability assessment. In this review, the development and functions of the BBB in zebrafish, such as its anatomical morphology, tight junctions, drug transporters and enzyme expression, are compared with those in mammals. The studies outlined in this review describe the utilization of the zebrafish as a BBB model to investigate the permeability and distribution of fluorescent dyes and drugs. Particularly, this review focuses on the use of zebrafish to evaluate the delivery of natural products and nanosized drug delivery systems across the BBB. Due to the highly conserved nature of both the structure and function of the BBB between zebrafish and mammals, zebrafish has the potential to be developed as a model for assessing and predicting the permeability of BBB to novel compounds.Entities:
Keywords: Blood brain barrier (BBB); Drug delivery systems; Fluorescence dyes; Natural products; Permeability; Zebrafish
Mesh:
Substances:
Year: 2017 PMID: 28867638 DOI: 10.1016/j.phrs.2017.08.017
Source DB: PubMed Journal: Pharmacol Res ISSN: 1043-6618 Impact factor: 7.658